These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16038484)

  • 1. Facial fat volume in HIV-infected patients with lipoatrophy.
    Yang Y; Sitoh YY; Oo Tha N; Paton NI
    Antivir Ther; 2005; 10(4):575-81. PubMed ID: 16038484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imaging.
    Paton NI; Yang Y; Tha NO; Sitoh YY
    HIV Clin Trials; 2007; 8(4):227-34. PubMed ID: 17720663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of three-dimensional laser scanning for the assessment of facial fat changes.
    Paton NI; Yang Y; Sitoh YY; Tha NO
    HIV Med; 2007 Nov; 8(8):498-503. PubMed ID: 17944682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
    J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-slice computed tomography and anthropometric skinfold analysis for evaluation of facial lipoatrophy in HIV-infected patients.
    Padilla S; Gallego JA; Masiá M; Gutiérrez F
    Clin Infect Dis; 2004 Dec; 39(12):1848-51. PubMed ID: 15578410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
    Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
    AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophy.
    Bickel M; Eisen J; Stephan C; Crespi CM; Lutz T; Klauke S; Vogl TJ; Jacobi V; Yang OO; Staszewski S; Zangos S
    HIV Med; 2007 Oct; 8(7):413-9. PubMed ID: 17760732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
    Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
    HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective assessment of facial lipoatrophy changes in a cohort of HIV-infected patients taking combination antiretroviral therapy.
    Yang Y; Yap M; Oo Tha N; Paton NI
    HIV Clin Trials; 2008; 9(6):399-406. PubMed ID: 19203905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report.
    Parruti G; Toro GM
    BMC Infect Dis; 2005 Oct; 5():80. PubMed ID: 16202141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus atropy induces modification of subcutaneous adipose tissue architecture: in vivo visualization by high-resolution magnetic resonance imaging.
    Josse G; Gensanne D; Aquilina C; Bernard J; Saint-Martory C; Lagarde JM; Schmitt AM
    Br J Dermatol; 2009 Apr; 160(4):741-6. PubMed ID: 19120341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy.
    Yang Y; Zhu WD; Paton NI
    Antivir Ther; 2004 Oct; 9(5):771-8. PubMed ID: 15535415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restorative interventions for HIV facial lipoatrophy.
    Carey D; Liew S; Emery S
    AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
    Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
    Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of fat partitioning in treated HIV-infection.
    Martínez E
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):415-27. PubMed ID: 21663836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary surgical management of HIV-associated facial lipoatrophy.
    Funk E; Bressler FJ; Brissett AE
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
    Cavalcanti RB; Raboud J; Shen S; Kain KC; Cheung A; Walmsley S
    J Infect Dis; 2007 Jun; 195(12):1754-61. PubMed ID: 17492590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.